KRAS: From function and genomics to clinical inhibition

Date 05 March 2016
Event ESMO Symposium on Signalling Pathways in Cancer 2016
Session Targeting the EGFR/HER family in NSCLC
Topics Anti-Cancer Agents & Biologic Therapy
Lung and other Thoracic Tumours
Translational Research
Presenter Chiara Ambrogio
Authors C. Ambrogio
  • Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 - Madrid/ES